# Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention

> **NCT00578396** · PHASE1 · WITHDRAWN · sponsor: **University of California, Irvine**

## Conditions studied

- Colon Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** grapes
- **DIETARY_SUPPLEMENT:** grapes
- **DIETARY_SUPPLEMENT:** grapes

## Key facts

- **NCT ID:** NCT00578396
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Non applicable clinical trial
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578396, "Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00578396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*